Dan Marks
Venture Senior Associate @ RA Capital Management
Boston, United States
Dan Marks is a Series A investor at RA Capital Management in Boston focused on Biotechnology. Dan Marks is the Principal at RA Capital Management, L.P. Dan Marks attended Gerstner Sloan Kettering Graduate School of Biomedical Sciences at Memorial Sloan Kettering Cancer Center.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Dan Marks invests in
Stages Dan Marks invests in
Countries Dan Marks invests in
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CDR-Life AG
|
CDR-Life is a Zurich-based biotech company that develops innovative therapeutic antibody fragments with a focus on immuno-oncology and ophthalmology. Our facilities are located in the Bio-Technopark in Schlieren-Zurich, Switzerland | $76M / Series A / Apr 13, 2022 |
Co-Investors
About RA Capital Management
RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.
RA Capital Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Cristina Ghenoiu
Principal
|
|||
Ajay Yekkirala
VP, Head of Biology
|
|||
Andrew Levin
Managing Director
|
|||
Barbara Herbst
Deputy Chief Compliance Officer
|
|||
|
Dan Marks
Venture Senior Associate
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Dan Marks invest in?
Dan Marks invests primarily in Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dan Marks last invest?
The most recent investment recorded for Dan Marks closed in Apr 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
